
Canada - TSX Venture Exchange - TSX-V:SVA - CA81752F1062 - Common Stock
The current stock price of SVA.CA is 0.135 CAD. In the past month the price decreased by -15.62%. In the past year, price decreased by -40%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| EPRX.CA | EUPRAXIA PHARMACEUTICALS INC | N/A | 441.67M | ||
| EDT.CA | SPECTRAL MEDICAL INC | N/A | 380.08M | ||
| HBP.CA | HELIX BIOPHARMA CORP | N/A | 176.44M | ||
| MDNA.CA | MEDICENNA THERAPEUTICS CORP | N/A | 127.62M | ||
| COV.CA | COVALON TECHNOLOGIES LTD | 24.25 | 53.19M | ||
| MBX.CA | MICROBIX BIOSYSTEMS INC | N/A | 34.18M | ||
| RVX.CA | RESVERLOGIX CORP | N/A | 28.67M | ||
| BCT.CA | BRIACELL THERAPEUTICS CORP | N/A | 26.23M | ||
| HEM.CA | HEMOSTEMIX INC | N/A | 15.64M | ||
| MPH.CA | MEDICURE INC | N/A | 10.86M | ||
| CSCI.CA | COSCIENS BIOPHARMA INC | N/A | 9.26M | ||
| QPT.CA | QUEST PHARMATECH INC | N/A | 6.77M |
Sernova Corp. is a clinical stage regenerative medicine company. The company is headquartered in London, Ontario. The firm is focused on developing and commercializing regenerative medicine therapeutics, including its Cell Pouch and associated technologies, including therapeutic cells and local cellular immune protection. The Cell Pouch is a scalable and implantable medical device. The Cell Pouch is designed to create a vascularized tissue environment for the transplantation and engraftment of therapeutic cells, which then release proteins and/or hormones for the long-term treatment of multiple chronic diseases, such as diabetes, hemophilia and thyroid disease. Its Cell Pouch combines with immune protected therapeutic cells, offers a protection from immune system attack. Its regenerative medicine therapeutic approach provides cell therapies, where the cells transplanted within an organ-like the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.
SERNOVA BIOTHERAPEUTICS INC
700 Collip Circle, Ste 114
London ONTARIO N6G 4X8 CA
CEO: Philip M. Toleikis
Employees: 0
Phone: 15198585126.0
Sernova Corp. is a clinical stage regenerative medicine company. The company is headquartered in London, Ontario. The firm is focused on developing and commercializing regenerative medicine therapeutics, including its Cell Pouch and associated technologies, including therapeutic cells and local cellular immune protection. The Cell Pouch is a scalable and implantable medical device. The Cell Pouch is designed to create a vascularized tissue environment for the transplantation and engraftment of therapeutic cells, which then release proteins and/or hormones for the long-term treatment of multiple chronic diseases, such as diabetes, hemophilia and thyroid disease. Its Cell Pouch combines with immune protected therapeutic cells, offers a protection from immune system attack. Its regenerative medicine therapeutic approach provides cell therapies, where the cells transplanted within an organ-like the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.
The current stock price of SVA.CA is 0.135 CAD. The price increased by 8% in the last trading session.
SVA.CA does not pay a dividend.
SVA.CA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
SERNOVA BIOTHERAPEUTICS INC (SVA.CA) operates in the Health Care sector and the Biotechnology industry.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on SVA.CA.
You can find the ownership structure of SERNOVA BIOTHERAPEUTICS INC (SVA.CA) on the Ownership tab.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |